A comprehensive real-world study analyzing over 11.4 million patients has validated the safety profile of ultrasound enhancing agents (UEAs) in echocardiographic procedures, with LUMASON® showing very low rates of serious complications.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.